Bloom SR - Search Results

1

Price SL, Bloom SR. Price SL, et al. Among authors: bloom sr. Front Horm Res. 2014;42:147-54. doi: 10.1159/000358343. Epub 2014 Apr 7. Front Horm Res. 2014. PMID: 24732932 Review.

2

Increased food intake with oxyntomodulin analogues.

Price SL, Minnion JS, Bloom SR. Price SL, et al. Among authors: bloom sr. Peptides. 2015 Nov;73:95-100. doi: 10.1016/j.peptides.2015.09.006. Epub 2015 Sep 30. Peptides. 2015. PMID: 26431789 Free PMC article.

3

Investigating the Glucagon Receptor and Glucagon-Like Peptide 1 Receptor Activity of Oxyntomodulin-Like Analogues in Male Wistar Rats.

Price SL, Minnion JS, Bloom SR. Price SL, et al. Among authors: bloom sr. Curr Ther Res Clin Exp. 2015 Nov 2;77:111-5. doi: 10.1016/j.curtheres.2015.10.003. eCollection 2015 Dec. Curr Ther Res Clin Exp. 2015. PMID: 26843896 Free PMC article.

4

CCK, PYY and PP: the control of energy balance.

Simpson K, Parker J, Plumer J, Bloom S. Simpson K, et al. Handb Exp Pharmacol. 2012;(209):209-30. doi: 10.1007/978-3-642-24716-3_9. Handb Exp Pharmacol. 2012. PMID: 22249816 Review.

5

Translational studies on PYY as a novel target in obesity.

Zac-Varghese S, De Silva A, Bloom SR. Zac-Varghese S, et al. Among authors: bloom sr. Curr Opin Pharmacol. 2011 Dec;11(6):582-5. doi: 10.1016/j.coph.2011.10.001. Epub 2011 Oct 21. Curr Opin Pharmacol. 2011. PMID: 22019565 Review.

6

The role of oxyntomodulin and peptide tyrosine-tyrosine (PYY) in appetite control.

Wynne K, Bloom SR. Wynne K, et al. Among authors: bloom sr. Nat Clin Pract Endocrinol Metab. 2006 Nov;2(11):612-20. doi: 10.1038/ncpendmet0318. Nat Clin Pract Endocrinol Metab. 2006. PMID: 17082808 Review.

7

The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans.

De Silva A, Salem V, Long CJ, Makwana A, Newbould RD, Rabiner EA, Ghatei MA, Bloom SR, Matthews PM, Beaver JD, Dhillo WS. De Silva A, et al. Among authors: bloom sr. Cell Metab. 2011 Nov 2;14(5):700-6. doi: 10.1016/j.cmet.2011.09.010. Epub 2011 Oct 13. Cell Metab. 2011. PMID: 22000927 Free PMC article. Clinical Trial.

8

No evidence of an additive inhibitory feeding effect following PP and PYY 3-36 administration.

Neary NM, McGowan BM, Monteiro MP, Jesudason DR, Ghatei MA, Bloom SR. Neary NM, et al. Among authors: bloom sr. Int J Obes (Lond). 2008 Sep;32(9):1438-40. doi: 10.1038/ijo.2008.95. Epub 2008 Jul 8. Int J Obes (Lond). 2008. PMID: 18607381 Clinical Trial.

9

L-Arginine Increases Postprandial Circulating GLP-1 and PYY Levels in Humans.

Amin A, Neophytou C, Thein S, Martin NM, Alamshah A, Spreckley E, Bloom SR, Murphy KG. Amin A, et al. Among authors: bloom sr. Obesity (Silver Spring). 2018 Nov;26(11):1721-1726. doi: 10.1002/oby.22323. Obesity (Silver Spring). 2018. PMID: 30358156 Free PMC article.

10

The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers.

Tan T, Behary P, Tharakan G, Minnion J, Al-Najim W, Albrechtsen NJW, Holst JJ, Bloom SR. Tan T, et al. Among authors: bloom sr. J Clin Endocrinol Metab. 2017 Jul 1;102(7):2364-2372. doi: 10.1210/jc.2017-00469. J Clin Endocrinol Metab. 2017. PMID: 28379519 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,725 results

Search Page